These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12420241)

  • 1. Hirudin for prophylaxis and treatment of deep vein thrombosis.
    Kemkes-Matthes B
    Semin Thromb Hemost; 2002 Oct; 28(5):455-8. PubMed ID: 12420241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant hirudin in the prevention of venous thromboembolism in patients undergoing elective hip surgery.
    Agnelli G; Sonaglia F
    Semin Thromb Hemost; 1997; 23(2):143-8. PubMed ID: 9200338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirudins for prophylaxis and treatment of venous thromboembolism.
    Prisco D; Falciani M; Antonucci E; Gensini GF
    Semin Thromb Hemost; 2001 Oct; 27(5):543-9. PubMed ID: 11668426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hirudin in acute coronary syndromes.
    van de Loo A; Bode C
    Semin Thromb Hemost; 2002 Oct; 28(5):459-66. PubMed ID: 12420242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F; Lindgaerde F; Eriksson H; Bassand JP; Wallmark A; Hansson PO; Grollier G; Sjo M; Moia M; Camez A; Smyth V; Walker M
    Thromb Haemost; 1997 May; 77(5):834-8. PubMed ID: 9184388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
    Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
    Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin-induced thrombocytopenia: a critical risk/benefit analysis of patients in intensive care treated with R-hirudin.
    Schenk JF; Berg G; Mörsdorf S; Stefan B; Kroll H; Krischek B; Pindur G; Schieffer H; Wenzel E
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):151-6. PubMed ID: 10898275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial treatment of venous thromboembolism.
    McRae SJ; Ginsberg JS
    Circulation; 2004 Aug; 110(9 Suppl 1):I3-9. PubMed ID: 15339875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery.
    Glotzbecker MP; Bono CM; Harris MB; Brick G; Heary RF; Wood KB
    Spine (Phila Pa 1976); 2008 Dec; 33(26):2915-21. PubMed ID: 19092624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice].
    Hirmerová J
    Vnitr Lek; 2006 Apr; 52(4):379-88. PubMed ID: 16755994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of intravenous recombinant hirudin in the treatment of deep vein thrombosis in a patient with an acute heparin allergy.
    Fields RM; Peppo W
    Ann Emerg Med; 2002 Aug; 40(2):155-8. PubMed ID: 12140493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolic risk and its prevention in hospitalized medical patients.
    Haas SK
    Semin Thromb Hemost; 2002 Dec; 28(6):577-84. PubMed ID: 12536351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis and treatment of deep vein thrombosis in general surgery.
    Gutt CN; Oniu T; Wolkener F; Mehrabi A; Mistry S; Büchler MW
    Am J Surg; 2005 Jan; 189(1):14-22. PubMed ID: 15701484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism prophylaxis in medical patients: future perspectives.
    Imberti D; Prisco D
    Thromb Res; 2005; 116(5):365-75. PubMed ID: 16122549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulants in the treatment of deep vein thrombosis.
    Merli G
    Am J Med; 2005 Aug; 118 Suppl 8A():13S-20S. PubMed ID: 16125510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.